Publications by authors named "Gabriela M Orgeron"
Article Synopsis
- A study examined aspirin (ASA) hypersensitivity in a cardiology practice, reviewing medical records of over 11,000 patients from 2012 to 2013.
- The prevalence of ASA hypersensitivity was found to be 1.88%, with skin reactions being the most common, and many patients misclassified based on symptoms like gastrointestinal issues.
- The findings indicate a significant lack of proper documentation and management of ASA hypersensitivity, highlighting the need for better referral processes for desensitization and addressing unwarranted avoidance of ASA in affected patients.
Background Despite growing use of the subcutaneous implantable cardioverter-defibrillator (S- ICD ), its clinical role in arrhythmogenic right ventricular cardiomyopathy/dysplasia ( ARVC /D) patients remains undefined. We aim to elucidate the cardiac phenotype, implant characteristics, and long-term efficacy regarding appropriate therapy and complications in ARVC /D patients with an S- ICD implant. Methods and Results A transatlantic cohort of ARVC /D patients who underwent S- ICD implantation was analyzed for clinical characteristics, S- ICD therapy, and long-term outcome including device-related complications.
View Article and Find Full Text PDFBackground: Ventricular arrhythmias are a feared complication of arrhythmogenic right ventricular dysplasia/cardiomyopathy. In 2015, an International Task Force Consensus Statement proposed a risk stratification algorithm for implantable cardioverter-defibrillator placement in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Methods And Results: To evaluate performance of the algorithm, 365 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients were classified as having a Class I, IIa, IIb, or III indication per the algorithm at baseline.
Background: Arrhythmogenic right ventricular dysplasia/cardiomyopathy is characterized by ventricular arrhythmias and sudden cardiac death. Once the diagnosis is established, risk stratification to determine whether implantable cardioverter-defibrillator (ICD) placement is warranted is critical.
Methods And Results: The cohort included 312 patients (163 men, age at presentation 33.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy is an inherited cardiomyopathy characterised by ventricular arrhythmias and an increased risk of sudden cardiac death. Arrhythmogenic right ventricular dysplasia/cardiomyopathy diagnosis is based on criteria that take into account electrical and structural cardiac abnormalities, as well as mutation analysis. Appropriate pharmacological therapy and the prevention of sudden death with implantable defibrillators are important in the management of these patients.
View Article and Find Full Text PDFArticle Synopsis
- ARVD/C is an inherited heart condition that leads to dangerous heart rhythms, right ventricular issues, and can cause sudden cardiac death.
- Since it was first identified in 1982, there have been significant improvements in how the disease is diagnosed and treated, including understanding its genetic causes and the impact of exercise.
- The 2010 update to the diagnostic criteria has made it easier to identify ARVD/C by using advanced methods to detect heart structure abnormalities.
Catheter-related atrial thrombosis is a potentially deadly complication of central venous catheters. Options for treatment include surgical thrombectomy, systemic anticoagulation, and systemic thrombolysis, but the optimal method of treatment remains unknown. We describe a 48-year-old woman with a large right atrial thrombus who was successfully treated with localized recombinant tissue plasminogen activator (tPA).
View Article and Find Full Text PDF